ARTICLE SUMMARY:
In this week’s Pathways Picks: A report from The MedTech Conference in Boston, including insights from FDA, CMS, AMA, EU, and UK officials. Updates on CDRH hiring efforts, EU reform timelines, AI policy moves in the US, UK, and EU, perspectives on the impending FDA-CMS RAPID program, and more from around the world.
CDRH “Herculean” Hiring

CDRH Director Michelle Tarver says the device center is making substantive progress toward rebuilding from last year’s massive staffing losses. Tarver told attendees of The MedTech Conference in Boston October 21 that her center experienced a 22%-25% attrition rate over the past year-plus, including about 30% of CDRH’s clinical reviewers and a “significant number of digital health and AI specialists.”
The turnover came in the context of the “reduction in force” and other Trump administration efforts in 2025 to reduce the federal government. But now, she affirmed, the course has shifted back to hiring. “We have been on a recruiting tear,” she said during the conference’s CDRH Townhall session. “We have actually exceeded our hiring for fiscal year 26 under the MDUFA commitment, which is a Herculean effort considering all the changes that have happened.” Tarver estimated more than 65 people have been hired back to CDRH’s offices in White Oak, Md., and she affirmed that there is more to come. There’s “a lot of work, and we need more hands to help us manage that work.”